Study Title | Pilot Study of Dinutuximab Sargramostim (GM-CSF) and Isotretinoin in Combination with Irinotecan and Temozolomide in the Post-Consolidation Setting for High-Risk Neuroblastoma |
---|---|
Protocol ID | ANBL19P1 |
Disease (Sub Disease) | Neuroblastoma |
Diagnosis Stage | New Diagnosis |
Sponsor | Children's Oncology Group |
Collaborators | National Cancer Institute (NCI) |
Links | https://clinicaltrials.gov/ct2/show/NCT04385277 |
Trial Status | Closed to Recruitment |
Trial Open Date | 30/11/2020 |
Study Type | Treatment |
Phase | Pilot |
Age Eligibility | up to 30 Years |
International registry ID's | NCT04385277 |